MoneyWorks4Me

Phaarmasia - Quaterly Results

11 Aug 2025 Evaluate
The sales slipped to Rs. 68.74 millions for the June 2025 quarter as against Rs. 82.92 millions during the year-ago period.Net profit declined -2.17% to Rs. 2.71 millions from Rs. 2.77 millions.Operating Profit saw a handsome growth to 4.05 millions from 3.31 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 68.74 82.92 -17.10 68.74 82.92 -17.10 243.69 305.93 -20.34
Other Income 3.15 1.48 112.84 3.15 1.48 112.84 7.46 6.62 12.69
PBIDT 4.05 3.31 22.36 4.05 3.31 22.36 -12.67 -1.58 701.90
Interest 0.27 0.03 800.00 0.27 0.03 800.00 0.16 0.44 -63.64
PBDT 3.78 3.28 15.24 3.78 3.28 15.24 -12.83 -2.02 535.15
Depreciation 0.64 0.79 -18.99 0.64 0.79 -18.99 3.20 3.44 -6.98
PBT 3.14 2.49 26.10 3.14 2.49 26.10 -16.03 -5.46 193.59
TAX 0.43 -0.28 -253.57 0.43 -0.28 -253.57 -0.13 -0.28 -53.57
Deferred Tax 0.43 -0.28 -253.57 0.43 -0.28 -253.57 -0.13 -0.28 -53.57
PAT 2.71 2.77 -2.17 2.71 2.77 -2.17 -15.90 -5.18 206.95
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) 5.89 3.99 47.60 5.89 3.99 47.60 -5.20 -0.52 906.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..